Company profile: Enchannel
1.1 - Company Overview
Company description
- Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
Products and services
- NanoAblate Pulsed Field Ablation Generator: Delivers non-thermal pulsed field ablation energy to heart tissue for treating arrhythmias via a dedicated generator platform
- DePolar 4D Cardiac Mapping System: Delivers real-time visualization of cardiac electrophysiology with clear maps that reveal arrhythmia mechanisms
- PFLine Ablation Catheter: Creates flexible lesion sets suitable for focal or linear ablation, enabling adaptable lesion formation patterns
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enchannel
CV Ingenuity
HQ: United States
Website
- Description: Provider of drug-coated balloon platforms for the “Touch-and-Go” treatment of vascular diseases, developing devices to relieve vascular obstructions, inhibit restenosis, and enable natural vessel healing; Palo Alto, CA-based.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CV Ingenuity company profile →
Vascular Therapies
HQ: United States
Website
- Description: Provider of biopharma solutions to improve vascular surgery outcomes in patients with kidney and vascular diseases, including Sirogen, a proprietary sirolimus formulation for local perivascular drug delivery, and ACCESS 2, a Phase 3 randomized clinical trial evaluating Sirogen’s effectiveness in improving AV fistula outcomes in elderly hemodialysis patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Therapies company profile →
Blue Medical
HQ: The Netherlands
Website
- Description: Provider of cardiovascular medical devices, including diamond-coated coronary stents, coronary stent systems, PTCA balloon catheters, and drug eluting solutions, designed and produced in its own production facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blue Medical company profile →
Advanced Perfusion Diagnostics
HQ: France
Website
- Description: Provider of innovative patient monitoring systems, developing, manufacturing and marketing solutions that deliver relevant tissue perfusion indicators to clinicians; based in Lyon, France, with the IKORUS monitoring system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Perfusion Diagnostics company profile →
Kestra Medical
HQ: United States
Website
- Description: Provider of wearable medical devices and cloud-based patient data platforms, offering the ASSURE Cardiac Recovery System—a wearable cardioverter defibrillator for detecting and defibrillating ventricular arrhythmias—Kestra CareStation for remote patient progress data and notifications, and the ASSURE Patient App to transmit heart rhythm data and support recovery monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kestra Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enchannel
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enchannel
2.2 - Growth funds investing in similar companies to Enchannel
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enchannel
4.2 - Public trading comparable groups for Enchannel
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →